Introduction
Cancer is a major public health problem in USA and worldwide, and it is estimated that 1,665,540 new cancer cases will be diagnosed and 585,720 deaths from cancer will occur in the USA in 2014 (Siegel et al. 2014) . Epidemiological and experimental data show that some cancers are caused by environmental factors, including exposure to complex mixtures such as carcinogenic polycyclic aromatic hydrocarbons (PAHs) from cigarette smoke, air, and water pollution. Several PAHs, including benzo(a)pyrene (BaP), have been listed by the US Environmental Protection Agency as probable human carcinogens (Agency 2003) .
Polycyclic aromatic hydrocarbons are procarcinogens that are converted into carcinogens by drug metabolizing enzymes, and the resulting reactive metabolites alkylate DNA or induce DNA damage that play essential roles in the initiation phase of carcinogenesis (Hecht 2003; Wogan et al. 2004) . For example, DNA adducts can cause miscoding events in critical genes (Hecht 2012) . Many DNA adducts Abstract The genotoxicity of a complex mixture [neutral fraction (NF) ] from a wood preserving waste and reconstituted mixture (RM) mimicking the NF with seven major polycyclic aromatic hydrocarbons (PAHs) and benzo(a)pyrene (BaP) was investigated by determining DNA adducts and tumor incidence in male B6C3F1 mice exposed to three different doses of the chemical mixtures. The peak values of DNA adducts were observed after 24 h, and the highest levels of PAH-DNA adducts were exhibited in mice administered NF + BaP, and the highest tumor incidence and mortality were also observed in this group. DNA adduct levels after 1, 7, or 21 days were significantly correlated with animal mortality and incidence of total tumors including liver, lung, and forestomach. However, only hepatic DNA adducts after 7 days significantly correlated serve as biomarkers of carcinogenic PAH exposure and cancer risk (Phillips and Venitt 2012; Poirier 1997; Urban et al. 2012 ). Significant positive linear correlations between levels of PAH-DNA adducts and cancer incidence have been reported in both epidemiological studies (Agudo et al. 2012; Tang et al. 2001; Veglia et al. 2008) and animal experiments (Culp et al. 1998 ). However, negative correlations between PAH-DNA adducts and tumor incidence have also been observed (Saieva et al. 2011; Siddens et al. 2012 ) and the mechanic relationships between carcinogen-DNA adducts and tumor formation are still not fully understood.
Gene/protein expression involved in DNA repair, apoptosis, and cell cycle regulation play very important roles in chemical carcinogenesis (Henkler et al. 2012; Suzuki et al. 2012) , and treatment with BaP alters expression of genes involved in xenobiotic metabolism, DNA repair, apoptosis, and cell cycle regulation (Hamouchene et al. 2011) . Initial recognition of DNA adducts is a key event regulating DNA damage repair (Sugasawa 2011) , and this includes nucleotide excision repair (NER). BaP-DNA adducts in liver and esophagus were significantly increased in DNA repair deficient mice compared to wild-type mice (John et al. 2012) . It was reported that apoptosis may also be associated with decreased BaP adduct levels (Zhou et al. 2010 ) and failure to induce apoptosis in human bronchial epithelial cells exposed to cigarette smoke resulted in enhanced neoplastic transformation (Du et al. 2012) .
Polycyclic aromatic hydrocarbons mixtures are known human carcinogens, and the potency of several individual compounds has been defined in animal studies; however, minimal information is available on potential interactions of complex mixtures of PAHs. Mixture interactions may alter the absorption, distribution, metabolism, or excretion of chemicals, and some chemicals in PAH mixtures may either inhibit or promote chemical carcinogenesis. Therefore, these interactions may effectively increase or decrease the potential toxicity or genotoxicity of the mixture (Tarantini et al. 2011) .
The current study investigated the genotoxicity and carcinogenicity of a single PAH-BaP, BaP plus a complex PAH mixture [neutral fraction (NF)] isolated from a wood preserving waste (WPW), and a reconstituted mixture (RM) containing BaP and six other major carcinogenic PAHs. The relationships between genotoxicity and carcinogenicity were studied, and expression of proteins involved in DNA repair, apoptosis, and cell cycle regulation was also investigated in tumor and normal liver tissues.
Materials and methods

Chemicals
Benz(a)anthracene (BaA), BaP, benzo(b)fluoranthene (BbF), benzo(k)fluoranthene (BkF), chrysene, and dibenz(a,h) anthracene (DA) were obtained from Sigma-Aldrich (St. Louis, MO). Indeno(1,2,3-c,d)pyrene (IP) was purchased from Absolute Standards (Hamden, CT). Materials for DNA extraction (Gupta 1984; Randerath et al. 1981; Reddy and Randerath 1986; ) and 32 P-postlabeling analysis (Phillips and Arlt 2007; Randerath et al. 1999; Reddy and Randerath 1986; Zhou et al. 2004 ) have been reported previously.
Extraction and PAH fractionation from complex chemical mixture Wood preserving waste, a non-aqueous phase liquid, was initially collected from a contaminated aquifer beneath a wood treatment plant. A liquid-liquid separation technique was used to separate this material into acid, base, and neutral fractions following the USEPA 3650B method (EPA (1996) . A 30 ml volume of WPW oil, 60 ml of methylene chloride (CH 2 Cl 2 ), and 60 ml sodium hydroxide (NaOH), pH 12, were added to a 2,000-ml separating funnel and shaken for 2 min. Once phases were separated, the upper aqueous layer (acid fraction) was removed and the lower organic layer (base/NF) was extracted two more times. One volume of base/NF, three volumes of 1 N H 2 SO 4 , and 1.5 volumes of CH 2 Cl 2 were shaken in a new separating funnel for 2 min. After the phases were separated, the organic phase was removed and aqueous phase was extracted one more time with CH 2 Cl 2 (same volume as first extraction). The two organic layers were combined to form the NF. The NF contains major carcinogenic PAHs (Fig. 1) , including BaA, BaP, BbF, chrysene, BkF, DA, and IP.
Preparation of a reconstituted mixture
Based on the composition of PAHs in the NF, seven major carcinogenic PAHs, which are defined as class B2 carcinogens by USEPA, were selected for a RM. The concentrations of each PAH in the RM were simulated to those in the NF. The final concentrations for animal treatment are listed in Table 1 .
Chemical analysis of the complex mixture
The analysis of the PAHs in the sample extracts was accomplished using a modified USEPA Method 8270C (GC/MS-SIM) as reported previously (Cizmas et al. 2003) . The quantification of the analytes was based on authentic standards and internal standards. The identification of the analytes was based on retention times and mass spectra (primary and confirmation ions). 
Animal experiments
Mice were housed in cages in a temperature-and humiditycontrolled facility with a daily photoperiod of 12 h light and 12 h dark. Animals were acclimatized for a week to the new environment, and then, the mice were randomly allocated to ten experimental groups with 35 mice for each group. Mice had free access to water, and fresh diet was provided in clean food bowls daily. The animals were subjected to a single intraperitoneal (i.p.) injection with BaP or a mixture of seven PAHs. Table 1 shows doses of PAHs applied in animal experiments. These chemicals, except for BaP, and their concentrations were similar to the residues extracted from the dense non-aqueous phase liquid collected at a wood preserving waste Superfund site (Phillips 2006) . These chemicals were dissolved in DMSO/corn oil (50:50). The vehicle volume for i.p. injection was about 7 µl per g body weight. Five animals were killed by CO 2 asphyxiation and cervical dislocation at 1, 7, and 21 days after the PAH treatment. Five mice served as a control and, therefore, were injected with the vehicle. Twenty to thirty mice for each group were maintained in the same environment for 280 days to observe tumor formation. Liver tissues were collected and were frozen in liquid nitrogen immediately and then stored at −80 °C until extractions of DNA and protein. Part of each tissue was fixed in paraformaldehyde (4 %) for histological examination. (Phillips and Arlt 2007; Zhou et al. 2005) . DNA was isolated by solvent extraction combined with enzymatic digestion of protein and RNA (Gupta 1984; Randerath et al. 1981 ) and stored at −80 °C until analysis. The nuclease P1-enhanced bisphosphate version of the 32 P-postlabeling method (Reddy and Randerath 1986 ) was used for analysis, with modifications of the chromatographic conditions (Mabon et al. 1996) . Briefly, DNA (10 μg) was enzymatically degraded to normal (Np) and modified (Xp) deoxyribonucleoside 3′-monophosphates with micrococcal nuclease and spleen phosphodiesterase at pH 6.0 and 37 °C for 3.5 h. After treatment of the mixture with nuclease P1 to convert normal nucleotides to nucleosides, modified nucleotides (Xp) were converted to 5′-32 P-labeled deoxyribonucleoside 3′,5′-bisphosphates (pXp) by incubation with carrier-free [γ-32 P]ATP and polynucleotide kinase. Radioactively labeled digests were applied to modified polyethyleneimine (PEI)-cellulose thin layers and chromatographed overnight (15-16 h) with 2.3 M sodium phosphate, pH 5.75 (D1), to purify bulky adducts. Labeled PAH adducts retained in the lower (L, 2.8 × 1.0 cm) part of the D1 chromatogram were, after brief autoradiography on Cronex 4 X-ray film, each contact-transferred to individual acceptor sheets and resolved by two-dimensional thin-layer chromatography (TLC). The bulky DNA adducts were separated with 3.82 M lithium formate, 6.75 M urea, pH 3.35 and 0.72 M sodium phosphate, 0.45 M Tris-HCl, 7.65 M urea, pH 8.2 in the first (D3) and second (D4) dimensions, respectively.
32 P-labeled DNA adducts were visualized by screen-enhanced autoradiography at −80 °C using Kodak XAR-5 film or with the aid of an InstantImager (Packard Instruments) . Appropriate blank count rates were automatically subtracted by the instrument from sample values. The extent of covalent DNA modification was calculated from corrected sample count rates, the amount of DNA assayed (expressed as pmol DNA monomer units or DNA-P), and the specific activity of [γ-32 P] ATP according to the following formula:
Quantitative data represented minimum estimates because 100 % recovery presumably was not achieved.
Reverse phase protein array (RPPA) assay
The assay of RPPA (Byers et al. 2012; Malinowsky et al. 2013 ) was performed in the Functional Proteomics Reverse Adducts/10 9 normal nucleotides
Phase Protein Array Core Facility at MD Anderson Cancer Center, Houston, TX. Briefly, tissue was lysed with RPPA lysis buffer and diluted in five twofold serial dilutions in dilution buffer (lysis buffer containing 1 % SDS). Serial diluted lysates were arrayed on nitrocellulose-coated FAST slides (Whatman, Inc, Piscataway, NJ) by an Aushon 2470 Arrayer (Aushon BioSystems, Billerica, MA). Each slide was probed with a validated primary antibody plus a biotinconjugated secondary antibody. The signal was amplified using a Dako Cytomation-catalyzed system (Dako North America, Inc. Varpinteria, CA) and visualized by DAB colorimetric reaction. The slides were scanned, analyzed, and quantified using the customized software Microvigene (VigeneTech Inc. North Billerica, MA) to generate spot intensity (He et al. 2012; Tibes et al. 2006 ).
Histological examination
At 280 days of age, surviving mice were euthanized by CO 2 asphyxiation, followed by cervical dislocation, and a number of tissues (liver, lung, and forestomach) examined first by gross necropsy and then fixed in 10 % formalin. Fixed tissues were routinely processed to paraffin blocks, and hematoxylin and eosin-stained sections were analyzed by a board-certified histopathologist as previously described (Shorey et al. 2012 ).
Statistical analysis
The relationships between values of PAH-DNA adducts at 1, 7, and 21 days and the mortality and tumor incidence were analyzed by linear regression analysis (Zar 2009 ). Statistical analysis of the data from individual mice was performed by using the unpaired and paired Student's t tests (Zar 2009 ).
Results
Profiles and levels of hepatic PAH-DNA adducts
For acute experiments, animals were terminated at 1, 7, and 21 days after PAH treatment. Profiles and levels of hepatic DNA adduct formation were determined. Representative profiles of hepatic DNA adducts in mice treated with BaP, BaP + NF, or RM are displayed in Fig. 2 . Typical patterns of PAH-DNA adducts are exhibited in all three groups with only slight differences. Total levels of PAH-DNA adducts for all chemical groups at three time points and three different doses are summarized in Table 2 . PAH-DNA adducts formed quickly within 1 day after PAH treatment. High levels of adducts were observed after 24 h, and they gradually decreased after 7 and 21 days. The NF + BaP groups showed higher levels of hepatic DNA adducts compared to the BaP or RM groups. Adduct levels at high doses were 81.6 ± 23.4, 276.5 ± 19.0, and 94.6 ± 14.9 in 10 9 normal nucleotides, respectively, for the BaP, NF + BaP, and RM groups. Analysis of all nine treatment groups (three doses and three time points) and comparison of DNA adduct levels between the NF + BaP and RM treatment by paired-sample t test (Zar 2009) showed that DNA adduct levels were significantly higher among the mice dosed with NF + BaP than those dosed with RM (P = 0.05). DNA adducts were also detected in mice 280 days after treatment with PAHs; however, hepatic PAH-DNA adducts were not observed at this time point (data not shown).
Histological observations
Acute histopathological changes were observed in the highdose RM group (Fig. 3A, panel b) . PAHs caused liver damage 7 days after treatment compared to the control group (Fig. 3A, panel a) . These results suggest that the high dose of carcinogenic PAHs not only induced genotoxicity, but also caused toxicity-based histological alterations.
Forty weeks after i.p. treatment with PAHs, tumor formation was observed in the liver, lung, and forestomach of B6C3F1 mice. The tumor incidence was greater in liver than in lung or forestomach (Table 3) . Upon dissection, gross liver tumor formation was observed (Fig. 3B , panel c) and histological analysis indicated that most liver tumors were hepatomas (Fig. 3B , panel e). High hepatic tumor incidence was observed in all three chemical groups.
The relationships between DNA adducts and mortality Mortality was measured by the number of dead animals observed prior to the end (280 days) of the study. The groups that were challenged with NF + BaP had higher mortality than the groups dosed with either BaP or the RM. Interestingly, levels of DNA adducts at 1, 7, and 21 days were significantly correlated with animal mortality (Fig. 4) . The higher the levels of hepatic DNA adducts displayed at early time points, the higher was the mortality. Hepatic DNA adduct values after 1 day exhibited the most significant correlation with mouse mortality (P < 0.001) compared to 7 (P < 0.002) and 21 days (P < 0.02). These results suggested that PAHs induced acute toxicity including genotoxicity could be associated with increased cancer-related mortality. PAH-DNA adducts could be also significant biomarkers for such mortality.
The relationships between DNA adducts and tumor incidence Tumor incidence for all groups was determined based on histological observation. Linear regression between PAH-DNA adducts and tumor incidence was determined and hepatic DNA adduct levels after 7 days significantly Control BaP NF+BaP RM Fig. 2 Typical representative profiles of 32 P-postlabeled PAH-DNA adducts detected in the livers of B6C3F1 mice. Animals were terminated at 1 day after PAH treatments. The circled spot is the benzo(a)pyrene-7,8-dihyrodiol-9,10-epoxide deoxy-guanosine (BPDE-dG) adduct High 94.6 ± 14.9 47.8 ± 5.4 37.6 ± 5.1 correlated with liver tumor incidence with P values being <0.02 (Fig. 5a ). Interestingly, hepatic DNA adducts may be not only biomarkers of liver tumors, but also biomarkers of tumors formed in other organs. Figure 5b shows that levels of hepatic DNA adducts after 1, 7, and 21 days were significantly correlated with tumor incidence in multiple organs (liver, lung, and forestomach). The P values are <0.01, <0.005, and <0.05 for 1, 7, and 21 days, respectively.
Comparisons of protein expression involved in DNA repair, apoptosis, and cell cycle regulation between tumor and normal tissues A panel of four normal and four tumor tissues was profiled by RPPA to identify differences in expression of protein involved in chemical carcinogenesis such as DNA repair, apoptosis, and cell cycle regulation. Protein lysate was collected from hepatic tumor samples and normal liver tissues, and it was evident that most DNA repair proteins including ATM, pATR, Chk1, pChk1, DNA PKcs, XRCC1, FANCD2, Ku80, Mre11, and Brca2 were expressed at significantly lower levels in tumor versus normal tissues (Table 4) . Expressions of proteins involved in apoptosis and cell cycle regulation were also significantly different in tumor versus non-tumor tissues. In tumor tissues, proteins PARP1, caspase3, caspase7, XIAP, p53, p-Rb (Ser807/811), and cyclin B1 were downregulated. In contrast, Bcl-xL, Bax, pBad (Ser112), and P16/INK4A were upregulated.
Discussion
Environmental PAHs are formed by the incomplete burning of hydrocarbons such as coal, gas, oil, and wood. They are generated from smoking, automobile exhaust, industrial activities, forest fires, and even grilled meats and are always found as mixtures in the environment and in biological tissues (Guo et al. 2011 ). In our current studies, we found there were seven major carcinogenetic PAHs in a NF extracted from a WPW dense non-aqueous phase liquid. This complex PAH mixture was carcinogenic in vivo, and similar results were previously reported for this mixture by Culp and coworkers (Culp et al. 1998) . RM was prepared based on the chemical compositions and relative PAH concentrations in the NF (Table 1) . However, the biological effects caused by these two mixtures were significantly different. Levels of DNA adducts, mortality, and tumor incidence in the NF groups were much higher compared to those in RM groups (Table 2 ). These results suggest that some PAHs or other unknown compounds that were present in the NF, but not in the RM, played an important role in the formation of DNA adducts and tumors induced by the NF. It was reported that PAHs in binary mixtures modulate the efficiency of BaP to form DNA adducts in human cells (Tarantini et al. 2011 ) and chromium(VI) exposure can greatly enhance the mutagenicity and cytotoxicity of PAHs by inhibiting the nucleotide excision repair (Hu et al. 2004) . Environmental factors including tobacco smoke, diet, and exposure to environmental and occupational carcinogens are believed to be responsible for many cancers (Stare and Jozefowicz 2008) , and for humans, PAHs are among most abundant chemical carcinogens in terms of levels and exposure. Most cancers are still not curable, and therefore, cancer prevention is an important anticancer strategy, particularly in high-risk populations such as smokers and others exposed to environmental and occupational carcinogens. Therefore, biomarkers of tumor formation are critical for the early detection of disease-related changes and the prediction of cancer risk (Kyrtopoulos 2006) . The 32 P-postlabeling assay was first developed in 1982 (Gupta et al. 1982 ) and was modified with nuclease P1-enhanced bisphosphate in 1986 (Reddy and Randerath 1986) . Because of its high sensitivity and requirement of <10 µg DNA, the 32 P-postlabeling assay (Phillips and Arlt 2007) has been applied in a number of human and animal studies of detection for DNA adducts. However, it is difficult for the 32 P-postlabeling assay to identify the structures of most carcinogen-DNA adducts. BPDE-dG (Jeffrey et al. 1977; Randerath et al. 1998 ) is one of the structureidentified carcinogen-DNA adducts (Fig. 2) . Our results showed that the BPDE-dG adduct has very similar trends with total DNA adducts. In future studies, high-resolution mass spectrometry (Klaene et al. 2012) or a combination of 32 P-postlabeling assay and mass spectrometry should be considered in detection and structure identification of DNA adducts (Farmer and Singh 2008) .
It was reported that complex PAH mixtures have been associated with increased cancer mortality (Warshawsky et al. 1996 ). In the current study, we observed that levels of PAH-DNA adducts detected at 1, 7, and 21 days after PAH treatment were significantly correlated with animal Correlations between hepatic DNA adduct levels (adducts in 10 9 normal nucleotides) at 1, 7, and 21 days, and mouse mortality prior to 280 days. Linear correlations were statistically significant for 1 day (P < 0.001), 7 days (P < 0.002), and 21 days (P < 0.02) mortality. Peak values of DNA adducts detected after 1 day may be a suitable predictor for general toxicity that is associated with the chronic adverse effects, including mortality.
The correlation between levels of PAH-DNA adducts and tumor incidence was also observed in this investigation. For example, hepatic PAH-DNA adducts detected after 7 days significantly correlated with liver tumor incidence at 280 days. Adduct levels after 1 and 21 days showed the trends of linear regressions, but the correlations were not significant (0.05 < P < 0.10). Interestingly, hepatic PAH-DNA adducts were significantly correlated with total tumor incidence in multiple organs (liver, lung, and forestomach) at 280 days, with P values being <0.01, <0.005, and <0.05 for 1, 7, and 21 days, respectively. Adduct levels after 7 days showed the best correlation with both liver tumor incidence and tumor incidence of multiple organs. One possible mechanism for these correlations could be that DNA repair systems that play important role A B Fig. 5 a Correlation between hepatic DNA adduct levels (adducts in 10 9 normal nucleotides) at 1, 7, and 21 days, and liver tumor incidence. Adduct levels detected at 7 days, but not at 1 or 21 days, were significantly correlated with liver tumor incidence. b Correlation between hepatic DNA adduct levels (adducts in 10 9 normal nucleotides) at 1, 7, and 21 days, and tumor incidence in multiple organs (liver, lung, and forestomach). Levels of hepatic DNA adducts at 1, 7, and 21 days were all significantly associated with tumor incidence in multiple organs (liver, lung, and forestomach) after initial DNA damage from PAH exposure may be compromised. PAH-DNA adducts rapidly activate nucleotide excision repair (Henkler et al. 2012) . Adducted nucleotides that were not repaired or removed within 7 days could lead to mutations. Accumulation of mutations is an important step for the tumor development (Vogelstein and Kinzler 2004) . Data obtained from RPPA indicated that some proteins involved in DNA repair such as ATM, pATR, Chk1, pChk1, Xrcc1, Ku80, Mre11, and apoptosis (PARP1, caspase3, caspase7, XIAP) were significantly decreased in liver tumors compared to normal liver tissues of B6C3F1 mice (Table 4) . These results suggest that genetic alterations, especially genes related to DNA repair and apoptosis pathways, may play important roles in PAH-mediated carcinogenesis. It was reported (Shi et al. 2004 ) that women with reduced DNA repair capacity were at an increased risk for developing breast cancer. Attenuation of DNA repair and apoptosis could increase the formation of carcinogen-DNA adducts (John et al. 2012) followed by DNA mutations and tumor formation. Our results indicate that proteins involved in cell cycle regulation showed both upregulation and downregulation. Similar results were reported by Hamouchene et al. (2011) who showed that BaP exposure increased gene expression of GDF15, JUN, RGC32, and EGR1, but decreased HDAC4 and Scaper. Thus, PAH-induced alterations in DNA repair and apoptotic pathways may facilitate persistent DNA adduct formation and changes in expression of these proteins or their corresponding mRNAs and may serve as biomarkers of exposure and risk. Future development and validation of these biomarkers at early time point after exposure are warranted. DNA adducts and their levels are important for tumor formation in rats after exposure to 2-nitrofluorene (Cui et al. 1995) , and our results also confirmed that DNA adducts could be useful biomarkers for tumor risk in mice after exposure to complex PAH mixtures. However, there are many factors involved in chemical carcinogenesis between formation of DNA adducts and tumor formation. Figure 6 shows a number of proteins/genes involved in DNA repair, apoptosis, and cell cycle regulation that may play important roles in chemical carcinogenesis. Dynamic observations of these proteins/genes after exposure to chemical carcinogens may help predict future tumor risk and facilitate understanding the mechanisms of chemical carcinogenesis and will be investigated in future studies.
